The category of Type II 4-phosphatase β Inhibitors would encompass a diverse array of compounds with the capability to modulate the activity of type II phosphatases or affect related cellular signaling cascades. These inhibitors operate through a variety of mechanisms, underscoring the complexity and critical nature of phosphatase functions in cellular processes. Direct inhibitors such as Sodium orthovanadate and Calyculin A demonstrate the capacity to alter signaling pathways by affecting the phosphorylation state of proteins. This modulation is essential for the regulation of numerous cellular functions, including growth, differentiation, and apoptosis, highlighting the significance of phosphatases in maintaining cellular homeostasis.
Moreover, the inclusion of compounds like Okadaic acid and Cantharidin offers insights into the regulatory mechanisms that govern cell cycle progression and signal transduction. Their specific inhibition of protein phosphatases like PP1 and PP2A points to the potential for targeted modulation of phosphatase activity as a means to study and influence the complex networks of cellular signaling. Additionally, natural toxins such as Microcystin-LR emphasize the potent effects that phosphatase inhibition can exert on cellular physiology, affecting a broad range of biological processes from cytoskeletal organization to gene expression.
In sum, this theoretical class of Type II 4-phosphatase β Inhibitors illustrates the critical roles that phosphatases play in regulating cellular functions and the potential for chemical compounds to influence these processes through direct or indirect interactions. By targeting the activity of these enzymes, it is possible to affect a wide array of biological pathways, offering a window into the sophisticated signaling networks that underpin cellular behavior. This approach not only provides a foundation for understanding the impact of phosphatase modulation on cell physiology but also underscores the intricate balance of phosphorylation and dephosphorylation events essential for proper cellular function.
Items 1 to 10 of 11 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
作为蛋白酪氨酸磷酸酶的竞争性抑制剂,可改变磷酸化状态。 | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
强烈抑制蛋白磷酸酶 1 和 2A,这可能会影响相关磷酸酶的活性。 | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
靶向蛋白磷酸酶 PP1 和 PP2A,可能会改变涉及类似磷酸酶的信号通路。 | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $81.00 $260.00 | 6 | |
抑制丝氨酸/苏氨酸磷酸酶,包括 PP2A,这可能会影响相关的磷酸酶信号传导。 | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $260.00 | 9 | |
PP2A 和 PP4 的选择性抑制剂,可影响由类似磷酸酶介导的信号通路。 | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
抑制 PP1 和 PP2A,影响相关酶的磷酸化动态和信号传导途径。 | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $48.00 $199.00 | 1 | |
对 PP2A 起作用,可能会影响涉及类似 II 型磷酸酶的途径。 | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $40.00 | 4 | |
结合并抑制酪氨酸磷酸酶,可能会影响相关酶的信号通路。 | ||||||
Bialaphos Sodium Salt | 71048-99-2 | sc-280620 sc-280620A | 100 mg 500 mg | $450.00 $992.00 | 1 | |
虽然它的主要作用是促进蛋白质合成,但也可能间接影响磷酸酶的活性。 | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $33.00 $102.00 | 87 | |
间接靶向参与 ER 应激的磷酸酶,可能会影响相关的酶。 |